These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1633423)

  • 1. Negative regulators of growth.
    Massagué J; Weinberg RA
    Curr Opin Genet Dev; 1992 Feb; 2(1):28-32. PubMed ID: 1633423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelial rat thyroid cell clones, escaping from transforming growth factor beta negative growth control, are still inhibited by this factor in the ability to trap iodide.
    Coppa A; Mincione G; Mammarella S; Ranieri A; Colletta G
    Cell Growth Differ; 1995 Mar; 6(3):281-90. PubMed ID: 7794796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGF-betal/Smad signaling in prostate cancer.
    Bello-DeOcampo D; Tindall DJ
    Curr Drug Targets; 2003 Apr; 4(3):197-207. PubMed ID: 12643470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to growth inhibition by transforming growth factor-beta in malignant glioma cells with functional receptors.
    Isoe S; Naganuma H; Nakano S; Sasaki A; Satoh E; Nagasaka M; Maeda S; Nukui H
    J Neurosurg; 1998 Mar; 88(3):529-34. PubMed ID: 9488308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin signaling: lessons from the Drosophila tuberous sclerosis complex, a tumor suppressor.
    Montagne J; Radimerski T; Thomas G
    Sci STKE; 2001 Oct; 2001(105):pe36. PubMed ID: 11675514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AZGP1 is a tumor suppressor in pancreatic cancer inducing mesenchymal-to-epithelial transdifferentiation by inhibiting TGF-β-mediated ERK signaling.
    Kong B; Michalski CW; Hong X; Valkovskaya N; Rieder S; Abiatari I; Streit S; Erkan M; Esposito I; Friess H; Kleeff J
    Oncogene; 2010 Sep; 29(37):5146-58. PubMed ID: 20581862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of transforming growth factor beta on human neuroendocrine tumor BON cell proliferation and differentiation is mediated through somatostatin signaling.
    Leu FP; Nandi M; Niu C
    Mol Cancer Res; 2008 Jun; 6(6):1029-42. PubMed ID: 18567806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular localization and chromosome mapping of a novel candidate tumor suppressor gene (ING1).
    Garkavtsev I; Demetrick D; Riabowol K
    Cytogenet Cell Genet; 1997; 76(3-4):176-8. PubMed ID: 9186514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The tumor suppressor ING1: structure and function.
    Cheung KJ; Li G
    Exp Cell Res; 2001 Aug; 268(1):1-6. PubMed ID: 11461112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The candidate tumour suppressor p33ING1 cooperates with p53 in cell growth control.
    Garkavtsev I; Grigorian IA; Ossovskaya VS; Chernov MV; Chumakov PM; Gudkov AV
    Nature; 1998 Jan; 391(6664):295-8. PubMed ID: 9440695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human resting CD4+ T cells are constitutively inhibited by TGF beta under steady-state conditions.
    Classen S; Zander T; Eggle D; Chemnitz JM; Brors B; Büchmann I; Popov A; Beyer M; Eils R; Debey S; Schultze JL
    J Immunol; 2007 Jun; 178(11):6931-40. PubMed ID: 17513742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGF beta regulation of epithelial cell proliferation: role of tumor suppressor genes.
    Moses HL; Pietenpol JA; Münger K; Murphy CS; Yang EY
    Princess Takamatsu Symp; 1991; 22():183-95. PubMed ID: 1844240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of transforming growth factor beta in the growth inhibition of human breast cancer cells by basic fibroblast growth factor.
    Fenig E; Kanfi Y; Wang Q; Beery E; Livnat T; Wasserman L; Lilling G; Yahalom J; Wieder R; Nordenberg J
    Breast Cancer Res Treat; 2001 Nov; 70(1):27-37. PubMed ID: 11767002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of transforming growth factor-beta signaling in human cancer: targeting a tumor suppressor network as a therapeutic strategy.
    Biswas S; Criswell TL; Wang SE; Arteaga CL
    Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4142-6. PubMed ID: 16857784
    [No Abstract]   [Full Text] [Related]  

  • 15. From growth arrest to growth suppression.
    Philipson L; Sorrentino V
    J Cell Biochem; 1991 Jun; 46(2):95-101. PubMed ID: 1717501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor suppressor gene Smad4/DPC4, its downstream target genes, and regulation of cell cycle.
    Chiao PJ; Hunt KK; Grau AM; Abramian A; Fleming J; Zhang W; Breslin T; Abbruzzese JL; Evans DB
    Ann N Y Acad Sci; 1999 Jun; 880():31-7. PubMed ID: 10415848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tumor suppressor activity of IKKalpha in stratified epithelia is exerted in part via the TGF-beta antiproliferative pathway.
    Marinari B; Moretti F; Botti E; Giustizieri ML; Descargues P; Giunta A; Stolfi C; Ballaro C; Papoutsaki M; Alemà S; Monteleone G; Chimenti S; Karin M; Costanzo A
    Proc Natl Acad Sci U S A; 2008 Nov; 105(44):17091-6. PubMed ID: 18957551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Function of the ING family of PHD proteins in cancer.
    Gong W; Suzuki K; Russell M; Riabowol K
    Int J Biochem Cell Biol; 2005 May; 37(5):1054-65. PubMed ID: 15743678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of the novel growth inhibitor p33ING1 promotes neoplastic transformation.
    Garkavtsev I; Kazarov A; Gudkov A; Riabowol K
    Nat Genet; 1996 Dec; 14(4):415-20. PubMed ID: 8944021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor suppressor genes in the TGF-beta signaling pathway?
    Serra R; Moses HL
    Nat Med; 1996 Apr; 2(4):390-1. PubMed ID: 8597940
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.